| P2093 | author name string | Hirokazu Nagawa | |
| | Tsuyoshi Takato | |
| | Hiroyuki Koyama | |
| | Tetsuro Miyata | |
| | Mikiko Nagayoshi | |
| | Tetsushi Taguchi | |
| P2860 | cites work | Integrins: bidirectional, allosteric signaling machines | Q27860700 |
| | Angiogenesis in cancer and other diseases | Q27861015 |
| | Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease | Q34134554 |
| | Fibronectin at a glance | Q34150530 |
| | Engineering vascularized skeletal muscle tissue | Q34427542 |
| | Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. | Q35676053 |
| | Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. | Q36002268 |
| | Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization | Q36321628 |
| | Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. | Q36593341 |
| | Biomaterials and scaffold design: key to tissue-engineering cartilage. | Q36709581 |
| | Progress and opportunities for tissue-engineered skin | Q36742022 |
| | Matrix metalloproteinases and their inhibitors in connective tissue remodeling | Q37174661 |
| | Vascularization in tissue engineering | Q37202076 |
| | Endothelial cell-matrix interactions: in vitro models of angiogenesis | Q38156188 |
| | Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains | Q38296534 |
| | A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor | Q41809330 |
| | A serum-free medium formulation supporting growth of human umbilical cord vein endothelial cells in long-term cultivation | Q41823225 |
| | Angiopoietin-related growth factor (AGF) promotes angiogenesis. | Q44756907 |
| | Ex vivo gene transfer of basic fibroblast growth factor improves cardiac function and blood flow in a swine chronic myocardial ischemia model | Q45863301 |
| | Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation | Q46567786 |
| | Controlled delivery of bFGF to recipient bed enhances the vascularization and viability of an ischemic skin flap | Q47965676 |
| | The growth of a vascular network inside a collagen-citric acid derivative hydrogel in rats | Q48018077 |
| | Development of a novel glue consisting of naturally-derived biomolecules: citric acid and human serum albumin. | Q51020603 |
| | pH-responsive swelling behavior of collagen gels prepared by novel crosslinkers based on naturally derived di- or tricarboxylic acids. | Q51115546 |
| | Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels. | Q51589439 |
| | Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. | Q51811203 |
| | Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis | Q74514715 |
| | Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial | Q74811727 |
| | Unusual cell adhesion and antithrombogenic behavior of citric acid-cross-linked collagen matrices | Q80373675 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydrogel | Q898925 |
| P304 | page(s) | 196-203 | |
| P577 | publication date | 2011-06-02 | |
| P1433 | published in | Annals of vascular diseases | Q26842879 |
| P1476 | title | Enhanced neovascular formation in a novel hydrogel matrix consisting of citric Acid and collagen | |
| P478 | volume | 4 | |